Joseph Burns
Joseph Burns is the senior editor of The Dark Report. An independent journalist in Falmouth, Mass., Burns has covered health care since 1991 and clinical laboratories since 2004. He writes for a variety of publications, including Managed Care magazine (where he is a contributing editor), Hospitals & Health Networks, and Healthcare Finance News. In addition, he is the insurance topic leader for the Association of Health Care Journalists and has worked as a writer and editor for The Commonwealth Fund, the Health Care Incentives Improvement Institute, the National Business Coalition on Health, the National Committee for Quality Assurance, and the National Quality Forum. Burns has edited books on health care business strategies for Faulkner & Gray and Panel Publishers and was editor-in-chief of Business & Health magazine, formerly published by Medical Economics Co., and later was a contributing editor and columnist for Managed Healthcare Executive magazine. He began his career as a journalist in Connecticut, working as a newspaper reporter for The Wallingford Post and the Meriden Record-Journal and as a copy editor, reporter, and regional news editor for The Hartford Courant, the nationās oldest newspaper. While working for The Courant, he taught news writing at the University of Connecticut.
Articles by Joseph Burns
FDA Replaces March 16 Serology COVID-19 Rules
From the Volume XXVII No. 7 – May 11, 2020 Issue
CEO SUMMARY: In the rush to allow companies and clinicalĀ laboratories to develop, validate, and bring to market serologicalĀ tests for COVID-19, the federal Food and Drug AdministrationĀ issued rules on March 16 that eased its requirements for theseĀ new assays. Because of the la…
Expert Offers Comments on FDA and Revised Serology Test Rules
From the Volume XXVII No. 7 – May 11, 2020 Issue
CLINICAL LABORATORY DIRECTORS areĀ asking what caused the federal FoodĀ and Drug Administration (FDA) toĀ issue a highly questionable policy in MarchĀ to allow serological tests for SARS-CoV-2Ā and then change that policy seven weeksĀ later. Under a policy the agency issuedĀ March…
New Lab Revenue Source: COVID-19 Worker Screening
From the Volume XXVII No. 7 – May 11, 2020 Issue
CLINICAL LABORATORIES have a newĀ revenue-generating opportunity,Ā as some states relax stay-at-homeĀ rules: Many employers are likely to seekĀ COVID-19 screening tests for employeesĀ returning to work to detect the presenceĀ of the new coronavirus. This new source of lab specimens andĀ revenue gi…
California Research Team Analyzes Performance of 12 Serology Tests
From the Volume XXVII No. 7 – May 11, 2020 Issue
CEO SUMMARY: Researchers with the COVID-19 Testing Project usedĀ a multidisciplinary effort to analyze and compare the performance of 12Ā serological tests. One finding is that, 16 to 20 days or more after a confirmedĀ infection with a molecular test, many of the 12 serological te…
To Stay Afloat, Dallas AP Group Cut Staff, Payroll
From the Volume XXVII No. 7 – May 11, 2020 Issue
CEO SUMMARY: As early cases of COVID-19 spread inĀ some states, pathologists at the 50-member ProPath group inĀ Dallas prepared for a widespread outbreak by preserving cashĀ and working with bankers and other advisors to apply for federalĀ stimulus funding. Executives also fur…
Companies Saw Big Drop in Lab Revenue from Mid-March
This is an excerpt of a 2,083-word article in the April 20, 2020 issue of THE DARK REPORT (TDR). The full article is available to members of The Dark Intelligence Group. CEO SUMMARY: In response to the coronavirus outbreak,Ā patients stopped seeing their doctors for routine c…
From Mid-March, Labs Saw Big Drop in Revenue
From the Volume XXVII No. 6 – April 20, 2020 Issue
CEO SUMMARY: In response to the coronavirus outbreak,Ā patients stopped seeing their doctors for routine care and hospitalsĀ ceased doing elective services. With fewer test referrals,Ā clinical labs and pathology groups were hit with a substantialĀ decline in revenue. One of t…
Labs May Qualify for Relief Under New Federal Laws
From the Volume XXVII No. 6 – April 20, 2020 Issue
CEO SUMMARY: After routine testing and specimen volumeĀ declined last month, so too did the associated revenue. InĀ response, clinical laboratories and anatomic pathology groupsĀ want to bolster their finances quickly or risk incurring moreĀ financial damage to already-fragile…
Italyās SARS-CoV-2 Outbreak Brings Out Best in Clinical Labs
From the Volume XXVII No. 6 – April 20, 2020 Issue
CEO SUMMARY: Italy was one of the first countriesĀ outside of China to experience an explosiveĀ outbreak of COVID-19 and its northern provincesĀ were hit hardest by this novel coronavirus. In this exclusive interview with THE DARK REPORT,…
DOJ Says Georgia Man Got Kickbacks for COVID-19 Tests
From the Volume XXVII No. 6 – April 20, 2020 Issue
JUST WEEKS AFTER THE FIRST CASES OF SARS-CoV-2 appeared in the UnitedĀ States, federal prosecutors filed criminalĀ charges in a COVID-19 lab test fraudĀ scheme. Erik Santos, 49, of Braselton, Ga.,Ā was charged with conspiracy to defraudĀ federal and private healthcare programsĀ by submitting fraudule…
CURRENT ISSUE
Volume XXXI, No. 4 – March 18, 2024
An expert attorney analyzes the most recent cases of EKRA violations, showing how many labs could be in violation themselves. Also, a major cyberattack on Change Healthcare, owned by UnitedHealth Group, creates disruptions to providers around the country. Other news includes a look at the worldwide pathologist shortage.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized